临床医学
臨床醫學
림상의학
CLINICAL MEDICINE
2014年
6期
124-125
,共2页
回生口服液%肝动脉化疗栓塞术%原发性肝癌
迴生口服液%肝動脈化療栓塞術%原髮性肝癌
회생구복액%간동맥화료전새술%원발성간암
Huisheng oral liquid%Transcatheter arterial chemoembolization%Primary liver cancer
目的：观察回生口服液联合肝动脉化疗栓塞术（TACE）治疗原发性肝癌（PLC）的疗效。方法将66例 PLC 患者随机分成两组，观察组33例给予回生口服液联合 TACE 治疗，对照组33例行 TACE。结果回生口服液能提高患者生活质量、调节免疫功能，并减少 TACE 的不良反应。结论回生口服液联合 TACE 是中晚期 PLC 患者的有效治疗方法。
目的：觀察迴生口服液聯閤肝動脈化療栓塞術（TACE）治療原髮性肝癌（PLC）的療效。方法將66例 PLC 患者隨機分成兩組，觀察組33例給予迴生口服液聯閤 TACE 治療，對照組33例行 TACE。結果迴生口服液能提高患者生活質量、調節免疫功能，併減少 TACE 的不良反應。結論迴生口服液聯閤 TACE 是中晚期 PLC 患者的有效治療方法。
목적：관찰회생구복액연합간동맥화료전새술（TACE）치료원발성간암（PLC）적료효。방법장66례 PLC 환자수궤분성량조，관찰조33례급여회생구복액연합 TACE 치료，대조조33례행 TACE。결과회생구복액능제고환자생활질량、조절면역공능，병감소 TACE 적불량반응。결론회생구복액연합 TACE 시중만기 PLC 환자적유효치료방법。
Objective To observe the efficacy of Huisheng oral liquid combined with transcatheter arterial chemoembolization (TACE)on primary liver cancer(PLC). Methods Sixty-six patients with PLC were randomly divided into two groups,33 pa-tients in the observation group received Huisheng oral liquid combined with TACE,and the 33 patients in the control group re-ceived TACE therapy only. Results Huisheng oral liquid could significantly improve the quality of life in patients with PLC,ad-just the patient’s immune function,and reduce the adverse reactions induced by TACE. Conclusion Huisheng oral liquid com-bined with TACE is an effective treatment for patients with advanced PLC.
